Zydus Cadila gets US FDA nod for Doxycycline capsules

Published On 2016-02-20 06:41 GMT   |   Update On 2016-02-20 06:41 GMT
New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market its generic Doxycycline capsules used for the treatment of bacterial infections in the American market.

"Zydus Cadila has received approval from the United States Food and Drug Administration (USFDA) to market Doxycycline capsules USP, 50 mg, 75 mg, and 100 mg," Cadila Healthcare said in a BSE filing.

The drug falls in the anti-bacterials segment, it added.

"With this first approval, the group will now commence supplies to the US market from its formulation manufacturing facility located at the SEZ in Ahmedabad," Cadila Healthcare said.

The group now has 102 approvals and has so far filed over 280 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04, it added.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News